Natural and synthetic compounds such as sulforaphane and the BET inhibitor JQ1 were found to inhibit STAT5-mediated transcription in CML and T-ALL cells, probably via epigenetic mechanisms [289,290]. Here, STAT5B is linked to chronic myelogenous leukemia, BCR-ABL1 positive.